An In Silico Platform to Predict Cardiotoxicity Risk of Anti-tumor Drug Combination with hiPSC-CMs Based In Vitro Study
ConclusionsIn conclusion, thein vitro-in vivo translational platform is capable of predicting systolic dysfunction incidence almost merely depend on hiPSC-CMs, which could facilitate optimizing the treatment protocol of antineoplastic agents.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Herceptin | Stem Cell Therapy | Stem Cells | Study | Toxicology